ArticleClinical kidney journal2021

Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification.

Antonio Bellasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.